Authum Inv & Infr has completed the allotment of Non-Cumulative Non-Convertible Redeemable Preference Shares (NCRPS) worth Rs 250 crores to its promoter, Mentor Capital Limited. The Fund Raising Committee of the Board approved this allotment at its meeting held on December 17, 2025.

Allotment Details

The company has provided updated details regarding the preference share allotment, which differs from earlier reported figures:

Regulatory Compliance

The allotment was conducted pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This follows the company's earlier intimation dated December 9, 2025, regarding the proposed allotment.

Strategic Implications

The preference shares carry a 0.01% dividend rate and are non-convertible, meaning they will not be converted into equity shares, thereby maintaining the current equity structure. Being non-cumulative, any unpaid dividends will not accumulate for future payment.

This capital infusion from the promoter group represents a strategic financial move that could support the company's growth initiatives and strengthen its capital base for future business expansion.

Authum Investment & Infrastructure Limited has successfully concluded its postal ballot process and filed the mandatory regulatory disclosure under Regulation 30 of SEBI Listing Obligations. The company announced on December 15, 2025, that shareholders overwhelmingly approved the Employee Stock Option Scheme 2025 with 92.20% support, followed by the required regulatory filing with stock exchanges.

Postal Ballot Results

The postal ballot conducted through remote e-voting concluded on December 12, 2025, with impressive shareholder participation:

Both resolutions related to the Employee Stock Option Scheme 2025 received identical voting results, indicating unanimous shareholder support for the initiative.

ESOP Scheme Framework and Regulatory Filing

Following shareholder approval, the company submitted its regulatory disclosure to NSE and BSE under Regulation 30, providing comprehensive details of the approved scheme:

The scheme encompasses options for both company employees and eligible employees of subsidiary companies, with the Nomination and Remuneration Committee overseeing implementation and administration.

Key Terms and Exercise Framework

The regulatory filing reveals important operational details of the ESOP scheme:

The exercise price will be determined by the Nomination and Remuneration Committee at the time of grant, ensuring compliance with applicable accounting standards and SEBI guidelines for employee share-based payments.

Compliance and Documentation

The postal ballot process was conducted with full regulatory compliance, with Mayank Arora & Co., Practicing Company Secretaries, serving as scrutinizer. The company's filing references SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155, demonstrating adherence to latest regulatory frameworks.

With 38,853 shareholders as of the November 7, 2025 cut-off date, the overwhelming approval reflects strong confidence in management's employee retention strategy. The scheme provides flexibility for future corporate actions while maintaining alignment with shareholder value creation objectives through proper regulatory oversight and transparent implementation processes.